2026-10-14T01:16:44Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34040763 2026-10-01T07:20:43Z category_37339 category_37354 category_37360 category_37366 portal_1012 item_type_6 month_year_10_2026

Supplementary Data1 from The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy Helen M.R. Robinson (15056123) Vera Grinkevich (15056096) Jayesh B. Majithiya (15056099) Sam E. Mann (25154070) Claire McWhirter (25154073) Eeson Rajendra (15056105) Marco Ranzani (15056060) Martin L. Stockley (15056108) Paula Costales (25154076) Owen A. Davis (25154079) Elias Elinati (18560211) Alessandro Galbiati (15056090) Lerin Geo (18560226) Ana Toste Rêgo (25154082) Bethany Mason (25154085) Lucy Armstrong (18560223) Diego Grande (15056093) Joana Neves (18560217) Marina Roy Luzarraga (25154088) Holly Cooper (25154091) Lucy Edwardes (25154094) Timothea Konstantinou (25154097) Marieke van de Ven (14938284) Ana Moises da Silva (25154100) Sarah C. Moser (25154103) Mark D. Charles (25154106) Harry Finch (25154109) Geoff S. Higgins (15056126) Simon J. Boulton (25154112) Jos Jonkers (14932452) Niall M.B. Martin (25154115) Robert A. Heald (15056117) Graeme C.M. Smith (15056120) Cancer Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Dna Damage And Repair DNA repair Drug Targets Pharmacology Precision Medicine Small Molecule Agents <p>Supplementary data to support the main figures</p> 2026-10-01T00:00:00Z Text Journal contribution 10.1158/1078-0432.34040763 https://figshare.com/articles/journal_contribution/Supplementary_Data1_from_The_Pharmacologic_Profile_of_ART6043_a_First-in-Class_Clinical_DNA_Polymerase_Theta_Polymerase_Domain_Inhibitor_Potentiating_PARP_Inhibitor_Efficacy/34040763 CC BY